Guo L - Search Results

1

Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.

Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X. Liu P, et al. Among authors: guo l. Onco Targets Ther. 2016 Aug 12;9:5049-59. doi: 10.2147/OTT.S108169. eCollection 2016. Onco Targets Ther. 2016. PMID: 27574446 Free PMC article.

2

Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system.

Guo L, Zhang H, Wang F, Liu P, Wang Y, Xia G, Liu R, Li X, Yin H, Jiang H, Chen B. Guo L, et al. Int J Nanomedicine. 2015 Jul 16;10:4535-47. doi: 10.2147/IJN.S85587. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26213467 Free PMC article.

3

Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.

Wang F, Zhang W, Guo L, Bao W, Jin N, Liu R, Liu P, Wang Y, Guo Q, Chen B. Wang F, et al. Among authors: guo q, guo l. Cancer Sci. 2014 Aug;105(8):1063-70. doi: 10.1111/cas.12458. Epub 2014 Jul 27. Cancer Sci. 2014. PMID: 24890366 Free PMC article.

4

Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.

Liu R, Wang Y, Li X, Bao W, Xia G, Chen W, Cheng J, Xu Y, Guo L, Chen B. Liu R, et al. Among authors: guo l. Drug Des Devel Ther. 2015 May 22;9:2705-19. doi: 10.2147/DDDT.S80948. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26045659 Free PMC article.

5

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer.

Guo L, Zhang H, Shao W, Chen B. Guo L, et al. Drug Des Devel Ther. 2015 Oct 3;9:5491-7. doi: 10.2147/DDDT.S91988. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26491259 Free PMC article. Review.

6

Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.

Guo L, Zhang H, Chen B. Guo L, et al. J Cancer. 2017 Feb 10;8(3):410-416. doi: 10.7150/jca.17144. eCollection 2017. J Cancer. 2017. PMID: 28261342 Free PMC article. Review.

7

Targeted photo-chemo therapy of malignancy on the chest wall while cardiopulmonary avoidance based on Fe3O4@ZnO nanocomposites.

Zhang H, Guo L, Ding S, Xiong J, Chen B. Zhang H, et al. Among authors: guo l. Oncotarget. 2016 Jun 14;7(24):36602-36613. doi: 10.18632/oncotarget.9123. Oncotarget. 2016. PMID: 27153557 Free PMC article.

8

Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo.

Guo L, Chen B, Liu R, Xia G, Wang Y, Li X, Wei C, Wang X, Jiang H. Guo L, et al. J Nanosci Nanotechnol. 2015 May;15(5):3710-9. doi: 10.1166/jnn.2015.9509. J Nanosci Nanotechnol. 2015. PMID: 26504996

9

Preclinical Assessment of Paclitaxel- and Trastuzumab-Delivering Magnetic Nanoparticles Fe₃O₄ for Treatment and Imaging of HER2-Positive Breast Cancer.

Guo L, Zhang H, Liu P, Mi T, Ha D, Su L, Huang L, Shi Y, Zhang J. Guo L, et al. Front Med (Lausanne). 2021 Oct 28;8:738775. doi: 10.3389/fmed.2021.738775. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34778301 Free PMC article.

10

Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis.

Zhang H, Guo L, Chen J. Zhang H, et al. Among authors: guo l. Onco Targets Ther. 2020 Apr 14;13:3085-3091. doi: 10.2147/OTT.S248436. eCollection 2020. Onco Targets Ther. 2020. PMID: 32341654 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,838 results

Search Page

Filters